Annual award announced for medical research charities wishing to benefit from AI
Award to help charities accelerate their medical research
BenevolentAI, one of the world’s largest private AI companies, in partnership with the Association of Medical Research Charities (AMRC) announced today it has created a new award, the BenevolentAI Award, to help charities accelerate their medical research and potentially develop new treatments and therapies using artificial intelligence.
The Award will be given to a single applicant once a year. BenevolentAI will offer the winning applicant access to the Company’s technology platform in order to solve specific research challenges the selected charity is facing. For example, to carry out deep investigation in a specific disease, create a better understanding of the disease, identify new areas and approaches in R&D and accelerate research towards new treatments and cures.
The deadline for submission is 31 January 2018. An Award judging panel consisting of Jackie Hunter, CEO of BenevolentBio, Aisling Burnand, CEO of the AMRC will access applications and choose a winner which will be announced at the AMRC & ABPI Patients First Conference on 20 March 2018.
Aisling Burnand MBE, Chief Executive of the AMRC, commented: “Getting new treatments to people affected by life threatening and life limiting illnesses is of paramount importance to medical research charities. To do this we have to constantly embrace innovation, new ways of thinking, new ways of funding and use every tool in the box. Increasingly our members are recognising the vital role that advanced technology can play in accelerating their work. The opportunity to have BenevolentAI work on a project for one of our members for a year is a very exciting prospect which could give that research process a huge kick start.”